AMH and fragile X syndrome: In a study that combined FXS family data from The Netherlands and the US, premutation carriers were found to have lower AMH levels than non-carriers at all ages (multi-level modeling, p < 0.0001) (Spath et al., 2011); As expected, AMH declined with increasing age among both premutation carriers and non-carriers.